跳至主要内容
临床试验/NCT02192372
NCT02192372已完成不适用

Impact of Metabolic Syndrome on Development of Contrast Induced Nephropathy After Elective Percutaneous Coronary Intervention

Ankara University1 个研究点 分布在 1 个国家目标入组 599 人开始时间: 2014年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
599
试验地点
1
主要终点
Contrast induced nephropathy

研究概览

简要总结

Prevention of contrast induced nephropathy after interventional cardiologic procedures deserves close interest because of its association with prolonged hospitalization, increased cost and increased in hospital and long term mortality rates. An observational prospective cohort study was designed to determine whether metabolic syndrome predicts the development of contrast induced nephropathy after elective percutaneous coronary intervention.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must be scheduled for elective percutaneous coronary intervention Clinical diagnosis of metabolic syndrome Patients must give informed consent

排除标准

  • Acute coronary events Acute renal failure End stage renal failure requiring hemodialysis Contrast allergy and exposure to nephrotoxic agent within 1 week before percutaneous coronary intervention Exposure to contrast agent within 1 week before the procedure.

结局指标

主要结局

Contrast induced nephropathy

时间窗: 24-48 hours after the percutaneous coronary intervention

Contrast induced nephropathy was defined as an increase in serum creatinine of \>25% or \>0.5 mg/dl above the baseline value 24 or 48 hours after angiography.

次要结局

  • glomerular filtration rate(48 hours after the percutaneous coronary intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Özgür Ulaş Özcan

MD

Ankara University

研究点 (1)

Loading locations...

相似试验